No Data
No Data
GeneDx Holdings Corp. Q1 2025 Earnings Preview
GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $115
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), GeneDx Holdings (WGS) and Teva Pharmaceutical (TEVA)
Earnings Preview: WGS to Report Financial Results Pre-market on April 30
Is GeneDx Holdings (NASDAQ:WGS) A Risky Investment?